Description
As the Trump administration begins its new term, significant changes in federal health policy and leadership are anticipated, particularly in areas like vaccines and public health initiatives. With Robert F. Kennedy leading HHS — alongside new leadership at the NIH, FDA, and CDC — questions arise about the direction of these agencies and the broader implications for public health. We’ll examine the evolving landscape, potential policy shifts, and their impact on public health in the years ahead.
